Rotavirus vaccines made available for use in humanitarian crises | The Daily Star
12:00 AM, April 25, 2021 / LAST MODIFIED: 12:00 AM, April 25, 2021

Rotavirus vaccines made available for use in humanitarian crises

Médecins Sans Frontières (MSF), Save the Children, UNICEF and the World Health Organisation (WHO) welcome the opportunity to make rotavirus vaccine available to more children living in humanitarian crises thanks to a landmark pricing agreement with the manufacturer, GlaxoSmithKline plc (GSK).

Children living in refugee camps, displaced communities or in other emergency situations now have a better chance of being protected against severe diarrhoeal disease with these lower price rotavirus vaccines. Diarrhoea is one of the leading causes of death among children under five.

For all latest news, follow The Daily Star's Google News channel.

The agreement makes use of the multi-partner Humanitarian Mechanism, launched in 2017. Rotavirus vaccine is the second vaccine  to be accessed through the scheme, which depends on manufacturers making their vaccines available at their lowest price for use in emergencies - across countries of all income levels. The first to be made available was the pneumococcal vaccine.

Rotavirus is the most common cause of severe diarrhoeal disease in children under 5 years globally, responsible for up to 200,000 child deaths each year. Children in refugee camps and displaced communities are among the most vulnerable in the world to such diseases, due to population density, poor hygiene and sanitation, and higher rates of malnutrition. Vaccination is therefore especially critical for these children, who may otherwise lack access to essential health services.

Source: World Health Organisation (WHO)

Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.

Grameenphone:
Type START <space> BR and send SMS it to 22222

Robi:
Type START <space> BR and send SMS it to 2222


Banglalink:
Type START <space> BR and send SMS it to 2225

Leave your comments

Top News

Top News

Top